Tag: Jim Shannon

The below Parliamentary question was asked by Jim Shannon on 2016-03-01.

To ask the Secretary of State for Health, what steps he is taking to ensure that most up-to-date treatments for women with pelvic floor related urinary conditions will be available on the NHS.

Jane Ellison

All treatments which are set out in the National Institute for Health and Care Excellence clinical guidelines for pelvic floor urinary conditions are available on the National Health Service.

The guidelines can be found here:

https://www.nice.org.uk/guidance/cg171/chapter/1-recommendations.

NHS England published new guidance on 16 November 2015 to help improve the care and experience of people with continence issues. This includes the most up to date evidence to support commissioners and providers. The guidance can be found on NHS England’s website and accessed via the following link:

https://www.england.nhs.uk/2015/11/16/continence-care/

“

The below Parliamentary question was asked by Jim Shannon on 2016-03-16.

To ask the Secretary of State for Transport, what discussions he has had with motor vehicle insurance companies on reducing the level of insurance premiums.

Andrew Jones

The Department for Transport has held a number of recent meetings with the motor insurance industry, for example to discuss young driver safety and technology measures which impact on the cost of insurance.

The Autumn Statement 2015 announced the Government will bring forward measures to reduce the excessive costs arising from unnecessary whiplash claims, and as the industry is competitive we expect average savings of £40 to £50 per motor insurance policy to be passed onto customers. Some insurers have already committed to pass on all savings to consumers as a result of the proposed changes.

The pricing of insurance products is a commercial matter for individual insurers in which the Government does not seek to intervene.

The below Parliamentary question was asked by Jim Shannon on 2016-03-17.

To ask the Secretary of State for Health, what discussions he has had with the International Lyme and Associated Diseases Society on use of results from the European Accredited Laboratory Assay related to Lyme disease to inform the provision of treatment on the NHS for that disease.

Jane Ellison

My Rt. hon. Friend the Secretary of State for Health has had no discussions with the International Lyme and Associated Diseases Society.

The below Parliamentary question was asked by Jim Shannon on 2016-04-18.

To ask the Secretary of State for the Home Department, what steps the Government is taking to ensure that terrorists cannot get into the UK from the Republic of Ireland.

James Brokenshire

The Government is working with Ireland to better safeguard our citizens from international terrorism by strengthening the external border of our shared Common Travel Area (CTA).

There is a high level of collaboration on a joint programme of work which includes, investment in border procedures, increased data sharing to inform immigration and border security decisions, interoperable passenger data systems, including the collection and processing of Advance Passenger Information (API) on intra and extra CTA routes, and harmonised visa policy and processes.

The below Parliamentary question was asked by Jim Shannon on 2016-04-21.

To ask the Secretary of State for Health, what discussions he has had with clinical bodies on research into the use of aspirin to reduce incidents of cancer.

Jane Ellison

Ministers have had no such discussions.

Achieving World-Class Cancer Outcomes A Strategy for England 2015-2020 includes a recommendation that NHS England should commission the National Institute for Health and Care Excellence (NICE) to develop updated guidelines for the use of drugs for the prevention of breast and colorectal cancers including the use of aspirin for individuals with hereditary non-polyposis colorectal cancer. Once these guidelines are published, clinical commissioning groups should ensure that general practitioners implement them. A National Cancer Transformation Board will oversee the implementation of the strategy, and an implementation plan will be published shortly.

The Strategy also noted that Cancer Research UK and the National Institute for Health Research will continue to monitor outcomes from trials under way in the United Kingdom and internationally regarding the role of aspirin in cancer prevention more generally. They will make evidence available to NHS England and NICE as results become clear.

The below Parliamentary question was asked by Jim Shannon on 2016-05-18.

To ask the Secretary of State for Business, Innovation and Skills, if he will take steps to increase the proportion of men going to university.

Joseph Johnson

The Government is committed to ensuring that everyone with the potential has the opportunity to benefit from higher education, irrespective of their background or gender.

In the last academic year we saw record numbers of applicants and entrants to higher education, including those from disadvantaged backgrounds.

In our recent guidance to the Director of Fair Access, we asked him to include among his areas of focus support for white working class boys who are among the groups with the lowest participation rates. Universities expect to spend more than £745 million through access agreements agreed with the Director of Fair Access on measures to improve access and success for students from disadvantaged backgrounds – up significantly from £404 million in 2009.

The below Parliamentary question was asked by Jim Shannon on 2016-05-19.

To ask the Secretary of State for Health, what research his Department is conducting on the use of biosimilars in healthcare.

George Freeman

The Department is not conducting and has not commissioned specific research on the use of biosimilars in healthcare.

The below Parliamentary question was asked by Jim Shannon on 2016-05-23.

To ask the Secretary of State for Energy and Climate Change, what assessment her Department has made of the potential merits of replacing traditional lattice pylons with the T-pylon in environmentally sensitive areas.

Andrea Leadsom

The T-Pylon is an innovative design that won a competition held in 2011 by the Royal British Institute of Architects, DECC and National Grid. The first scheme in which the use of the T-pylon has been proposed is for some sections of the Hinkley Point C Electric Line connection that was granted development consent by the Secretary of State on 19 January 2016. The decision to grant consent was made on the merits of the scheme based on a report and recommendation from the Planning Inspectorate. The Planning Inspectorate’s report and the Secretary of State’s decision can be found at:

http://infrastructure.planninginspectorate.gov.uk/projects/south-west/hinkley-point-c-connection/.

“

The below Parliamentary question was asked by Jim Shannon on 2016-06-06.

To ask the Secretary of State for Foreign and Commonwealth Affairs, what assessment he has made of UN Secretary-General’s report on Children and Armed Conflict and its Annex, published in April 2016, in which the Saudi-led Coalition is listed as committing grave violations against children in Yemen.

Mr Tobias Ellwood

We are aware of the UN Secretary General’s annual report on Children in Armed Conflict which was published on 2 June, which includes a section outlining the impact of the conflict in Yemen on children. The conflict in Yemen has had a significant impact on children, in terms of the numbers of child casualties, the recruitment of children as soldiers, and attacks on hospitals and schools. We consider all these reports very carefully. We note the announcement by the UN Secretary General on 6 June that removed the listing of the Saudi Arabian-led Coalition from the report’s annex, pending the conclusion of a joint review by the UN and Saudi Arabia on the cases and numbers cited in the text. We welcome co-operation between the UN and Saudi Arabia to look in to this matter.

The below Parliamentary question was asked by Jim Shannon on 2016-06-08.

To ask the Secretary of State for Health, what assessment he has made of the potential merits of providing on the NHS laser-guided shoes to people with Parkinson’s disease.

Jane Ellison

No assessment has been made of the potential merits of providing laser-guided shoes to people with Parkinson’s disease (PD) on the National Health Service. We understand this new innovation, whilst promising, remains at a relatively early stage in terms of development and testing. Good quality evidence from clinical trials would be needed before clinicians and commissioners could make appropriate assessments about the clinical and cost effectiveness of the shoes and consider their suitability for patients with PD.